Heidi Leblanc
Alpine Immune Sciences (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research, Chemokine receptors and signaling
Most-Cited Works
- → Apo2L/TRAIL and its death and decoy receptors(2003)848 cited
- → In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates(2014)587 cited
- → Death Receptor Recruitment of Endogenous Caspase-10 and Apoptosis Initiation in the Absence of Caspase-8(2001)523 cited
- → Tumor-cell resistance to death receptor–induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax(2002)506 cited
- → TWEAK Attenuates the Transition from Innate to Adaptive Immunity(2005)240 cited
- → A phase II, randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of MDX‐1100, a fully human anti‐CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis(2011)195 cited
- → Immune-stimulating antibody conjugates elicit robust myeloid activation and durable antitumor immunity(2020)195 cited
- → A Novel, Fully Human Anti–fucosyl-GM1 Antibody Demonstrates Potent In Vitro and In Vivo Antitumor Activity in Preclinical Models of Small Cell Lung Cancer(2018)50 cited
- → The mitotic centromeric protein MEI-S332 and its role in sister-chromatid cohesion(1999)39 cited
- → Topological analysis of the Rhodobacter capsulatus PucC protein and effects of C-terminal deletions on light-harvesting complex II(1996)29 cited